These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30920339)

  • 41. Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.
    Callahan PM; Terry AV; Tehim A
    Psychopharmacology (Berl); 2014 Sep; 231(18):3695-706. PubMed ID: 24595504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of α7-nicotinic acetylcholine receptor in a rat model of chronic nicotine-induced mechanical hypersensitivity.
    Zhang Y; Sevilla A; Weller R; Wang S; Gitlin MC; Candiotti KA
    Neurosci Lett; 2021 Jan; 743():135566. PubMed ID: 33352289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.
    Freitas K; Negus SS; Carroll FI; Damaj MI
    Br J Pharmacol; 2013 Jun; 169(3):567-79. PubMed ID: 23004024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors.
    Knott VJ; Fisher DJ; Millar AM
    Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P50 sensory gating, cognitive deficits and depressive symptoms in first-episode antipsychotics-naïve schizophrenia.
    Li S; Yu B; Wang D; Xia L; Wang L; Chen D; Xiu M; Zhang XY
    J Affect Disord; 2023 Mar; 324():153-161. PubMed ID: 36587903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
    Knott V; Millar A; Fisher D; Albert P
    Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.
    Perkins KA; Roy Chengappa KN; Karelitz JL; Boldry MC; Michael V; Herb T; Gannon J; Brar J; Ford L; Rassnick S; Brunzell DH
    Neuropsychopharmacology; 2018 May; 43(6):1334-1342. PubMed ID: 29185480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of nicotinic acetylcholine receptors in behavioral abnormalities and psychological dependence in schizophrenia-like model mice.
    Noda Y; Uchida M; Mouri A; Yamada S; Goto S; Kitagaki S; Mamiya T; Kushima I; Arioka Y; Ozaki N; Yoshimi A
    Eur Neuropsychopharmacol; 2020 Dec; 41():92-105. PubMed ID: 33109433
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia.
    Kohlhaas KL; Robb HM; Roderwald VA; Rueter LE
    Biochem Pharmacol; 2015 Oct; 97(4):482-487. PubMed ID: 26032639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice.
    Bouvrais-Veret C; Weiss S; Andrieux A; Schweitzer A; McIntosh JM; Job D; Giros B; Martres MP
    Neuropharmacology; 2007 Jun; 52(8):1691-700. PubMed ID: 17512560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task.
    Wood C; Kohli S; Malcolm E; Allison C; Shoaib M
    Neuropharmacology; 2016 Jun; 105():106-113. PubMed ID: 26772970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of modulation of the α7 nicotinic acetylcholine receptor on nicotine reward in the mouse conditioned place preference test.
    Jackson A; Alkhlaif Y; Papke RL; Brunzell DH; Damaj MI
    Psychopharmacology (Berl); 2019 Dec; 236(12):3593-3599. PubMed ID: 31302720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication.
    Oranje B; Glenthøj BY
    Schizophr Bull; 2014 Sep; 40(5):1022-9. PubMed ID: 24106334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
    Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
    Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor.
    Gurun MS; Parker R; Eisenach JC; Vincler M
    Anesth Analg; 2009 May; 108(5):1680-7. PubMed ID: 19372354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder.
    Olincy A; Blakeley-Smith A; Johnson L; Kem WR; Freedman R
    J Autism Dev Disord; 2016 Dec; 46(12):3812-3817. PubMed ID: 27565651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
    Lopes C; Pereira EF; Wu HQ; Purushottamachar P; Njar V; Schwarcz R; Albuquerque EX
    J Pharmacol Exp Ther; 2007 Jul; 322(1):48-58. PubMed ID: 17446300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.
    Turetsky BI; Dent G; Jaeger J; Zukin SR
    Psychopharmacology (Berl); 2012 May; 221(1):39-52. PubMed ID: 22048129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.